ATE357506T1 - Flavobakterium heparinum expressions-system - Google Patents

Flavobakterium heparinum expressions-system

Info

Publication number
ATE357506T1
ATE357506T1 AT01942668T AT01942668T ATE357506T1 AT E357506 T1 ATE357506 T1 AT E357506T1 AT 01942668 T AT01942668 T AT 01942668T AT 01942668 T AT01942668 T AT 01942668T AT E357506 T1 ATE357506 T1 AT E357506T1
Authority
AT
Austria
Prior art keywords
expression system
flavobacterium heparinum
heparinum
flavobacterium
expression
Prior art date
Application number
AT01942668T
Other languages
English (en)
Inventor
Hongsheng Su
Shao Zhongqi
Ana Lydia Tkalec
Francoise Blain
Joseph Zimmerman
Original Assignee
Biomarin Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomarin Pharm Inc filed Critical Biomarin Pharm Inc
Application granted granted Critical
Publication of ATE357506T1 publication Critical patent/ATE357506T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT01942668T 2000-01-21 2001-01-16 Flavobakterium heparinum expressions-system ATE357506T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17756800P 2000-01-21 2000-01-21

Publications (1)

Publication Number Publication Date
ATE357506T1 true ATE357506T1 (de) 2007-04-15

Family

ID=22649110

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01942668T ATE357506T1 (de) 2000-01-21 2001-01-16 Flavobakterium heparinum expressions-system

Country Status (8)

Country Link
US (2) US6841375B2 (de)
EP (1) EP1252291B1 (de)
JP (1) JP2003520598A (de)
AT (1) ATE357506T1 (de)
AU (1) AU5790801A (de)
CA (1) CA2397562A1 (de)
DE (1) DE60127381D1 (de)
WO (1) WO2001053474A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6131811A (en) 1998-05-29 2000-10-17 E-Micro Corporation Wallet consolidator
DE60127381D1 (de) * 2000-01-21 2007-05-03 Biomarin Pharm Inc Flavobakterium heparinum expressions-system
CA2455827C (en) * 2001-08-13 2015-06-09 University Of Florida Research Foundation, Inc. Materials and methods for nerve grafting comprising degrading chondroitin sulfate proteoglycan
ATE481478T1 (de) 2002-06-03 2010-10-15 Massachusetts Inst Technology Rationell konstruierte, von chondroitinase b abgeleitete lyasen
CA2505472A1 (en) 2002-11-11 2004-05-27 Affymetrix, Inc. Methods for identifying dna copy number changes
US7691613B2 (en) 2006-11-03 2010-04-06 Momenta Pharmaceuticals, Inc. Glycosaminoglycan lyase IV and uses thereof
US7767420B2 (en) * 2005-11-03 2010-08-03 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
US7691612B2 (en) 2005-11-03 2010-04-06 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
US8200440B2 (en) * 2007-05-18 2012-06-12 Affymetrix, Inc. System, method, and computer software product for genotype determination using probe array data

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0515698B1 (de) * 1990-12-07 1998-07-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Verfahren zur Herstellung von D-Alpha-Aminosäuren
US5681733A (en) * 1994-06-10 1997-10-28 Ibex Technologies Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum
US6093563A (en) * 1994-07-08 2000-07-25 Ibex Technologies R And D, Inc. Chondroitin lyase enzymes
DE60127381D1 (de) * 2000-01-21 2007-05-03 Biomarin Pharm Inc Flavobakterium heparinum expressions-system

Also Published As

Publication number Publication date
WO2001053474A3 (en) 2002-01-17
EP1252291A2 (de) 2002-10-30
JP2003520598A (ja) 2003-07-08
AU5790801A (en) 2001-07-31
CA2397562A1 (en) 2001-07-26
EP1252291B1 (de) 2007-03-21
US20050153398A1 (en) 2005-07-14
WO2001053474A2 (en) 2001-07-26
DE60127381D1 (de) 2007-05-03
US20010034043A1 (en) 2001-10-25
WO2001053474A8 (en) 2001-08-30
US6841375B2 (en) 2005-01-11

Similar Documents

Publication Publication Date Title
DK0698105T3 (da) Nukleotidsekvenser til styring af ekspressionen af DNAsekvenser i en værtscelle
GB2355459B (en) A dominant conditional lethal genetic system
BR0108396A (pt) Derivados de pirimidina-4-0na como inibidores de ldl-pla(2)
EP1476562A4 (de) Überexpression von extremozymgenen in pseudomonas und nahe verwandte bakterien
AU2002238418A1 (en) Use of DNA repair enzymes as MMP-1 inhibitors
ATE450605T1 (de) Phytase enzyme, dafür kodierende nukleinsäuren, und solche enthaltende vectoren und wirtszellen
DE60127381D1 (de) Flavobakterium heparinum expressions-system
ATE492631T1 (de) Verwendung von mutationen zur verbesserung von aspergillus-phytasen
DE69923676D1 (de) Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
EP1699469A4 (de) Rekombinanter faktor viii mit erhöhter spezifischer aktivität
ATE372330T1 (de) N-sulfonylurea-apoptosis-förderer
TR200200494T2 (tr) Yağlı asit sintazı inhibitörleri.
DK1339853T3 (da) Isolerede luciferaser og deres anvendelse
ATE422558T1 (de) Reca-negativ und rhab-negativ mikroorganismus
DE60210970D1 (de) Mutante formen von etxb und ctxb und ihre verwendung als träger
WO2002057456A3 (en) Regulators of fungal gene expression
MXPA03008984A (es) D-hidantoinasa de ochrobactrum anthropi.
ATE273394T1 (de) Wirts-vektor-systeme zur phosphatregulierten überproduktion von polypeptiden in bacillus
PL1664307T3 (pl) Nowy, specyficzny dla bielma promotor roślinny dla roślin uprawnych
DE60310708D1 (de) In vivo stabilsierung von plasmiden
AU2002952143A0 (en) Use of bifunctional alpha-amylase/subtilisin inhibitor promoter to direct expression in the pericarp of plants
MX9702141A (es) Procedimiento para la produccion asi como para el uso de acarviosil-transferasa en la transformacion de homologos de acarbosa en acarbosa, para la produccion de homologos de acarbosa.
WO2003064465A3 (en) Prkag3 gene promoter and uses thereof
AU2003903132A0 (en) Plant promoter
DK1261325T3 (da) Tumorinhiberende sammensætninger, der indeholder nitroacridiner

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties